MONTANOVA CAPITAL, LLC bought BNTC
November 7, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 751,111 shares of Benitec Biopharma Inc. at $13.50 per share, a transaction worth $10.14M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
751,111
Price
$13.50
Total value
$10.14M
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateNovember 7, 2025
Filing dateNovember 10, 2025
Shares owned after1,819,812
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.